Inhibition of TGFBR1 activity by orally active specific inhibitors [28,32] or competitive inhibition of TGFB1 by a soluble form of TGFBR2 [33] dampens cardiac remodeling after MI. Here, TGFB1 is linked to myocardial infarction.